• Blog Post

Genoa Healthcare® Chief Operating Officer provides industry outlook in Chain Drug Review article

Feb 2nd, 2023

The importance of pharmacy as an accessible point in care will remain a focal point in the health care industry in 2023. Genoa Healthcare Chief Operating Officer Tasha Hennessy discussed the expanded role of the pharmacist and what that means for improving access to care in Chain Drug Review’s recent industry outlook article.

“As key partners in the delivery of care, pharmacists are in a unique position to drive positive behavioral changes and improve clinical outcomes in 2023,” said Hennessy. “With more than 670 pharmacies nationwide, Genoa Healthcare is ready to help, and we look forward to making a big difference in even more communities this year.”

You can read the full article here.  

Recent Posts


  • Blog Post
In-house, pharmacy management partnership or outsource? Questions to ask before choosing an on-site pharmacy model

Want to compare your options quickly? Download this overview. You’ve probably heard the benefits of adding a pharmacist to your care team. On-site pharmacies help break down barriers to care,...

  • Blog Post
340B made easy: 5 traits to look for in a contract pharmacy partner

The 340B Drug Pricing Program helps participating organizations – or covered entities – use savings on prescription drug costs to offer more comprehensive services and care for more eligible patients....

  • Blog Post
340B 101: What your clinic needs to know

For qualified clinics and organizations, the 340B Drug Pricing Program offers savings on prescription drug costs, helping boost offerings and outcomes for people who need it most. Wondering if your...

  • Blog Post
  • Webinar
The 340B Program information you’re looking for

For qualified clinics and organizations, the 340B Drug Pricing Program offers savings on prescription drug costs, helping boost offerings and outcomes for people who need it most. Wondering if your...